We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
+35.97%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$392M
AUM Growth
+$211M
Cap. Flow
-$13.1M
Cap. Flow %
-3.35%
Top 10 Hldgs %
58.69%
Holding
189
New
48
Increased
30
Reduced
62
Closed
47

Top Sells

Rank Stock Value
1
SKT icon
Tanger
SKT
+$3.39M
2
CPRI icon
Capri Holdings
CPRI
+$3.29M
3
PLCE icon
Children's Place
PLCE
+$3.19M
4
DHIL
Diamond Hill
DHIL
+$2.37M
5
WW
WW International
WW
+$1.88M

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.58%
2 Industrials 7.12%
3 Consumer Discretionary 6.24%
4 Technology 5.36%
5 Financials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEF icon
1
PUT
iShares S&P 100 ETF
OEF
$20B
$153M 39.12%
+535,300
New +$87.4M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$16.2M 4.12%
43,200
+28,700
+198% +$10.2M
XSLV icon
3
PUT
Invesco S&P SmallCap Low Volatility ETF
XSLV
$246M
$14.9M 3.8%
+145,000
New +$5.41M
HRB icon
4
CALL
H&R Block
HRB
$5.56B
$11.2M 2.84%
703,500
+649,000
+1,191% +$11.2M
IPO icon
5
PUT
Renaissance IPO ETF
IPO
$144M
$10M 2.56%
+155,700
New +$9.19M
KGC icon
6
CALL
Kinross Gold
KGC
$33B
$5.5M 1.4%
+749,500
New +$5.97M
HRB icon
7
H&R Block
HRB
$5.56B
$5.01M 1.28%
315,898
+39,883
+14% +$689K
KGC icon
8
Kinross Gold
KGC
$33B
$4.74M 1.21%
645,489
+492,256
+321% +$3.92M
LRN icon
9
Stride
LRN
$3.41B
$4.64M 1.18%
218,587
+114,787
+111% +$2.85M
HSII
10
DELISTED
Heidrick & Struggles
HSII
$4.62M 1.18%
157,259
-55,239
-26% -$1.39M
CHL
11
DELISTED
China Mobile Limited
CHL
$4.42M 1.13%
+154,826
New +$4.79M
MG icon
12
Mistras Group
MG
$617M
$4.3M 1.1%
554,035
+66,114
+14% +$345K
PARA
13
CALL
DELISTED
Paramount Global Class B
PARA
$4.18M 1.07%
112,300
+49,800
+80% +$1.6M
PRU icon
14
Prudential Financial
PRU
$40.4B
$4.06M 1.03%
51,948
+16,956
+48% +$1.23M
TZOO icon
15
Travelzoo
TZOO
$57.8M
$3.63M 0.93%
384,481
-2,585
-0.7% -$22.2K
LUMN icon
16
CALL
Lumen
LUMN
$6.88B
$3.22M 0.82%
330,500
WKC icon
17
World Kinect Corp
WKC
$1.81B
$3.18M 0.81%
+101,952
New +$2.72M
VYX icon
18
NCR Voyix
VYX
$982M
$3.06M 0.78%
132,625
-60,801
-31% -$1.01M
CVSA
19
Covista Inc
CVSA
$4.33B
$3.02M 0.77%
88,899
+17,486
+24% +$499K
MIK
20
DELISTED
Michaels Stores, Inc
MIK
$3M 0.76%
230,562
-27,161
-11% -$276K
CSTE icon
21
Caesarstone
CSTE
$99.2M
$2.93M 0.75%
227,602
+120,712
+113% +$1.38M
Z icon
22
PUT
Zillow
Z
$7.04B
$2.91M 0.74%
+22,400
New +$2.48M
SKT icon
23
Tanger
SKT
$4.11B
$2.82M 0.72%
283,167
-401,602
-59% -$3.39M
BHC icon
24
Bausch Health
BHC
$2.13B
$2.8M 0.71%
134,695
-45,169
-25% -$843K
FBP icon
25
First Bancorp
FBP
$4.22B
$2.79M 0.71%
302,682
-201,355
-40% -$1.53M

Similar funds

Invenomic Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Invenomic Capital Management held 189 positions worth $392M, up 116% from $182M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Invenomic Capital Management withdrew a net $13.1M in Q4 2020, closing 47 positions and reducing 62 holdings. Its most notable exit was F5, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Invenomic Capital Management opened a new position in China Mobile Limited worth $4.42M.

  • Invenomic Capital Management's largest Q4 2020 buy was China Mobile Limited: 154,826 shares worth $4.42M.
  • Invenomic Capital Management added most to Kinross Gold in Q4 2020, an estimated $3.92M increase.
  • Invenomic Capital Management's biggest Q4 2020 reduction was Tanger, cutting an estimated $3.39M.
  • Invenomic Capital Management fully exited F5 in Q4 2020, selling an estimated $1.62M.
  • Invenomic Capital Management's ten largest holdings make up 59% of its $392M portfolio in Q4 2020.
  • Invenomic Capital Management opened 48 new positions and closed 47 in Q4 2020.
  • Invenomic Capital Management's portfolio value rose 116% quarter-over-quarter to $392M.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.